Medicare Enrolled

Dr. Alvin Wells, MD

Rheumatology · Destin, FL
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
137 CRYSTAL BEACH DR STE 121, Destin, FL 32541
8508074388
Registered in NPPES since 2006
NPI: 1134234859 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Wells from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Wells? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Wells

Dr. Alvin Wells is a rheumatology specialist in Destin, FL, with 20 years of NPI registration. Based on federal Medicare data, Dr. Wells performed 391 Medicare services in 2023. These records do not provide a deduplicated patient total.

Between the years covered by Open Payments, Dr. Wells received a total of $2,511,261 from 73 pharmaceutical and/or device companies across 3554 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Wells is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years of NPI registration ▲ 391 Medicare services $2,511,261 industry payments

Florida License Status

FL DOH · MQA
1
Active license
None
Board action on record
0
Recent admin complaints
Profession License # Status Expires Board Action
Medical Doctor 169775 Clear January 31, 2028
Data from Florida Department of Health Medical Quality Assurance. License records are public under Chapter 119, Florida Statutes. Verify directly on FL DOH →

Medicare Practice Summary — 2023

Medicare Utilization ↗
391
Medicare services
Bottom 18% in FL for rheumatology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
Not available
Unique patients (not deduplicated)
$62
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
242 $65 $490
New patient office visit, complex (60-74 min) 31 $123 $895
Telephone medical discussion, 5-10 minutes
A phone conversation with a physician lasting between 5 and 10 minutes to discuss medical matters.
30 $23 $180
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
26 $42 $330
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
26 $36 $290
Ultrasound-guided large joint aspiration or injection
This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint.
24 $45 $1,203
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
12 $84 $720
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.

Industry Payment Transparency

Open Payments through 2024 ↗
$2,511,261
Total received (2018-2024)
Avg $358,752/year across 7 years
Top 0% in FL for rheumatology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
73
Companies
3,554
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$367,362
2023
$380,860
2022
$372,993
2021
$252,363
2020
$282,279
2019
$440,294
2018
$415,111

Payments by company (2024)

GENZYME CORPORATION
$128,188
ABBVIE INC.
$78,041
Amgen Inc.
$30,905
UCB, Inc.
$27,810
AstraZeneca Pharmaceuticals LP
$17,390
ANI Pharmaceuticals, Inc.
$16,584
GlaxoSmithKline, LLC.
$15,218
Novartis Pharmaceuticals Corporation
$9,286
PFIZER INC.
$7,398
Lilly USA, LLC
$6,784
Alexion Pharmaceuticals, Inc.
$6,468
Genentech USA, Inc.
$5,834
Janssen Scientific Affairs, LLC
$4,442
Kyowa Kirin, Inc.
$3,800
Takeda Pharmaceuticals U.S.A., Inc.
$3,372
Aurinia Pharma U.S., Inc.
$1,664
Mallinckrodt Hospital Products Inc.
$1,546
Biogen, Inc.
$954
Insmed, Inc.
$691
Janssen Biotech, Inc.
$245
Boehringer Ingelheim Pharmaceuticals, Inc.
$164
United Therapeutics Corporation
$146
Teva Pharmaceuticals USA, Inc.
$145
E.R. Squibb & Sons, L.L.C.
$98
SOBI, INC
$63
Sandoz Inc.
$45
Celltrion USA Inc.
$25
Radius Health, Inc.
$24
Actelion Pharmaceuticals US, Inc.
$16
IDORSIA PHARMACEUTICALS US INC
$14
Top 3 companies account for 64.6% of 2024 payments
All-time payments by company (2018-2024) ›
GENZYME CORPORATION
$359,701
AbbVie Inc.
$246,376
Lilly USA, LLC
$246,156
ABBVIE INC.
$209,534
Celgene Corporation
$183,502
GlaxoSmithKline, LLC.
$156,961
Amgen Inc.
$145,869
Aurinia Pharma U.S., Inc.
$103,447
AbbVie, Inc.
$102,179
UCB, Inc.
$96,414
Novartis Pharmaceuticals Corporation
$82,420
E.R. Squibb & Sons, L.L.C.
$72,295
AstraZeneca Pharmaceuticals LP
$70,451
Regeneron Healthcare Solutions, Inc.
$66,962
Alexion Pharmaceuticals, Inc.
$42,027
Eli Lilly and Company
$39,449
PFIZER INC.
$38,180
United Rheumatology
$36,609
NOVARTIS PHARMACEUTICALS CORPORATION
$25,070
Boehringer Ingelheim Pharmaceuticals, Inc.
$23,584
Sandoz Inc.
$22,487
ANI Pharmaceuticals, Inc.
$20,723
Mallinckrodt Hospital Products Inc.
$20,288
Merck Sharp & Dohme Corporation
$19,601
Horizon Therapeutics plc
$17,029
Janssen Scientific Affairs, LLC
$12,405
IDORSIA PHARMACEUTICALS US INC
$11,235
Octapharma USA, Inc.
$7,340
Avion Pharmaceuticals
$7,327
Genentech USA, Inc.
$7,130
Kyowa Kirin, Inc.
$3,800
Takeda Pharmaceuticals U.S.A., Inc.
$3,485
Otsuka Pharmaceutical Co., Ltd.
$2,000
Exeltis, USA Inc.
$1,724
Gilead Sciences, Inc.
$1,524
SANOFI-AVENTIS U.S. LLC
$1,075
Biogen, Inc.
$954
Insmed, Inc.
$691
Horizon Pharma plc
$545
Janssen Biotech, Inc.
$525
Assertio Therapeutics, Inc.
$355
Arcutis Biotherapeutics, Inc.
$231
Radius Health, Inc.
$222
Supernus Pharmaceuticals, Inc.
$154
United Therapeutics Corporation
$146
Teva Pharmaceuticals USA, Inc.
$145
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$116
Regeneron Pharmaceuticals, Inc.
$109
Mallinckrodt LLC
$101
SOBI, INC
$63
Celltrion USA Inc.
$62
Ferring Pharmaceuticals Inc.
$62
Ultragenyx Pharmaceutical Inc.
$40
Collegium Pharmaceutical, Inc.
$34
Egalet US Inc
$30
Actelion Pharmaceuticals US, Inc.
$29
AMAG Pharmaceuticals, Inc.
$25
Sobi, Inc
$23
Mallinckrodt Enterprises LLC
$22
Fresenius Kabi USA, LLC
$20
Incyte Corporation
$19
FIDIA PHARMA USA INC.
$18
Flexion Therapeutics, Inc.
$18
Pharming Healthcare, Inc.
$16
Novo Nordisk Inc
$16
Vertical Pharmaceuticals, LLC
$15
Oyster Point Pharma, Inc.
$15
Ironwood Pharmaceuticals, Inc
$15
Tactile Systems Technology Inc
$14
Pernix Therapeutics Holdings, Inc.
$14
Eisai Inc.
$13
Bioventus LLC
$12
MEDAC PHARMA, INC.
$11
Top 3 companies account for 33.9% of all-time payments
Associated products mentioned in payments ›
ABRILADA · ACTHAR · AJOVY · AVSOLA · Actemra · Arikayce · BELSOMRA · BENLYSTA · Bimzelx · COSENTYX · CUTAQUIG · CUVITRU · CYLTEZO · Cimzia · Crysvita · DUEXIS · DUZALLO · Dayvigo · EUCRISA · EUFLEXXA · EVENITY · Enbrel · FLEXITOUCH · FORTEO · GELSYN 3 · Gloperba · HUMIRA · HYRIMOZ · Humira · Hymovis · IDACIO · ILARIS · INFLECTRA · JARDIANCE · KEVZARA · KEVZARA SARILUMAB INJECTION · KRYSTEXXA · Kineret · LORZONE · LUCEMYRA · LUPKYNIS · LYRICA · Nucynta · OCTAGAM IMMUNE GLOBULIN (HUMAN) · OFEV · OLUMIANT · OPSUMIT · OPSUMIT MACITENTAN · OPZELURA · ORENCIA · OTREXUP · Otezla · PANZYGA · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · QUVIVIQ · RAYOS · REMICADE · RENFLEXIS · RHEUMATOID ARTHRITIS DISEASE · RINVOQ · RUCONEST · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SILENOR · SIMPONI · SIMPONI ARIA · SKYRIZI · SPRIX · STELARA · STRENSIQ · SYMLINPEN · SYNAGIS · Saxenda · Sotyktu · Strensiq · TALTZ · TAVNEOS · TOFIDENCE · TREMFYA · TROKENDI XR · TYRVAYA · Tavneos · Truxima · Tymlos · UBRELVY · UPLIZNA · Uloric · VYLEESI · XELJANZ · XTAMPZAER · YUFLYMA · Zilretta
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a rheumatology specialist in Destin?
Compare rheumatologists in the Destin area by procedure volume, costs, and industry payment transparency.
Browse rheumatologists nearby

Geographic Context

Rheumatologists in nearby ZIP areas
4
County median income
$79,097
Nearest hospital to ZIP centroid (approximate)
SACRED HEART HOSPITAL ON THE EMERALD COAST
8.0 mi

Data Sources

Provider Registry NPPES NPPES snapshot; verify current record
Medicare Enrollment PECOS PECOS snapshot
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Wells is a clinical cardiology specialist, with moderate Medicare volume, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Wells experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Wells performed 242 office visit, established patient (30-39 min) services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Wells receive payments from pharmaceutical companies?
Yes. Dr. Wells received a total of $2,511,261 from 73 companies across 3,554 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Wells's costs compare to other rheumatologists in Destin?
Dr. Wells's average Medicare payment per service is $62. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Wells) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →